Jamil M. Beg

• Joined Quaker BioVentures as an Analyst in January 2007
• Previously: Worked at Cambridge Pharma Consultancy (now IMS Consulting) as a life science management consultant. Contributed to strategic solutions for start-ups and multinational firms within the pharma, biotech, medical device, and diagnostics industries. Experiences encompass a broad range of therapeutic areas across settings of care in both developed and developing markets. Project work includes market assessments and commercialization, policy, and global launch strategy development. Worked in the University of Pennsylvania's Department of Bioengineering's molecular biophysics lab studying cellular adhesion and motility.
• Education: B.S.E. in Bioengineering and Master in Biotechnology in Biomedical Technologies from the University of Pennsylvania